Hirsch-Moverman, Yael
Mantell, Joanne E.
Lebelo, Limakatso
Howard, Andrea A.
Hesseling, Anneke C.
Nachman, Sharon
Frederix, Koen
Maama, Llang Bridget
El-Sadr, Wafaa M.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (1K01A104351)
National Institute of Mental Health (MH43520)
Article History
Received: 5 June 2019
Accepted: 14 May 2020
First Online: 25 May 2020
Ethics approval and consent to participate
: The study was approved by the Columbia University Irving Medical Center Institutional Review Board (Ref #IRB-AAAN7358) and the National Health Research Ethics Committee in Lesotho (Ref #ID78–2015). The overall study was registered at ClinicalTrials.gov (ExternalRef removed). All participants provided written, informed consent prior to participation. Consent was facilitated by providing individuals with a detailed study description and an adequate opportunity to ask questions. Providers were informed that their study participation was voluntary, all responses would be kept confidential and anonymized, and their decision to participate would have no impact on their employment.
: No information related to individual patients is presented in this study.
: The authors have no competing interests to declare.